Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Dec;15(12):e71141.
doi: 10.1002/brb3.71141.

Association of Peripheral Blood Neutrophil-Lymphocyte Ratio With Motor and Cognitive Function in Prodromal Parkinson's Disease

Affiliations

Association of Peripheral Blood Neutrophil-Lymphocyte Ratio With Motor and Cognitive Function in Prodromal Parkinson's Disease

Jin-Sun Jun et al. Brain Behav. 2025 Dec.

Abstract

Introduction: Neutrophil and lymphocyte levels and their ratio, the neutrophil-lymphocyte ratio (NLR), in the peripheral blood provide accessible indices of systemic inflammatory activity. In this study, we evaluated whether these blood markers are linked to motor symptoms and cognitive performance during the prodromal stage of Parkinson's disease (PD).

Methods: We analyzed data from the prodromal cohort of the Parkinson's Progression Markers Initiative, which included 1,269 individuals with prodromal PD features (isolated REM sleep behavior disorder [RBD]: n = 116, isolated hyposmia: n = 570, combined: n = 583) and 284 healthy controls. Motor impairment was measured using the Movement Disorder Society Unified Parkinson's Disease Rating Scale Part 3, while cognition was assessed through a broad neuropsychological test battery.

Results: Compared with controls, participants with prodromal PD had lower lymphocyte counts (p < 0.001) and higher NLR values (p = 0.008), whereas neutrophil counts did not differ between the groups (p = 0.749). No significant differences were observed across prodromal phenotypes for these markers. Correlation analysis demonstrated that NLR, but not neutrophil or lymphocyte counts alone, was associated with more severe motor impairment after false discovery rate correction (Q = 0.011). This relationship was evident in participants with both RBD and hyposmia and those with hyposmia only. However, the interaction between phenotype and NLR on motor severity was not significant. There were no significant associations of neutrophil or lymphocyte profiles with cognitive performance.

Conclusion: Our findings indicate that higher NLR, largely reflecting reduced lymphocyte levels, is already present in the prodromal phase of PD and relates to the severity of motor symptoms. Prospective longitudinal studies are needed to clarify whether NLR has predictive value for progression to overt PD.

Keywords: Parkinson's disease; REM sleep behavior disorder; neutrophil‐lymphocyte ratio; prodromal.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Flow diagram of participant selection Abbreviations: PD = Parkinson's disease.
FIGURE 2
FIGURE 2
Comparisons of blood neutrophil and lymphocyte counts and the NLR between patients with prodromal PD and controls. For (A) neutrophil count, (B) lymphocyte count, and (C) NLR, the box plot shows the interquartile range, with the horizontal bar representing the median. Whiskers indicate the range from minimum to maximum values, while outliers >1.5 times the interquartile range are excluded. Abbreviations: CI = confidence interval; NLR = neutrophil‐to‐lymphocyte ratio; PD = Parkinson's disease.
FIGURE 3
FIGURE 3
Comparisons of blood neutrophil and lymphocyte counts and the NLR according to distinct prodromal phenotypes. For (A) neutrophil count, (B) lymphocyte count, and (C) NLR, the box plot shows the interquartile range, with the horizontal bar representing the median. Whiskers indicate the range from minimum to maximum values, while outliers >1.5 times the interquartile range are excluded. Abbreviations: NLR = neutrophil‐to‐lymphocyte ratio; RBD = REM sleep behavior disorder.

References

    1. Aarsland, D. , Batzu L., Halliday G. M., et al. 2021. “Parkinson Disease‐Associated Cognitive Impairment.” Nature Review Disease Primers 7, no. 1: 47. - PubMed
    1. Berg, D. , Borghammer P., Fereshtehnejad S. M., et al. 2021. “Prodromal Parkinson Disease Subtypes—Key to Understanding Heterogeneity.” Nature Reviews Neurology 17, no. 6: 349–361. - PubMed
    1. Bovenzi, R. , Conti M., Simonetta C., et al. 2025. “Sex‐Specific Immune‐Biological Profiles in Parkinson's Disease.” Journal of Neuroimmunology 403: 578610. - PubMed
    1. Brochard, V. , Combadière B., Prigent A., et al. 2009. “Infiltration of CD4+ Lymphocytes Into the Brain Contributes to Neurodegeneration in a Mouse Model of Parkinson Disease.” Journal of Clinical Investigation 119, no. 1: 182–192. - PMC - PubMed
    1. Chen, X. , Hu Y., Cao Z., Liu Q., and Cheng Y.. 2018. “Cerebrospinal Fluid Inflammatory Cytokine Aberrations in Alzheimer's Disease, Parkinson's Disease and Amyotrophic Lateral Sclerosis: A Systematic Review and Meta‐Analysis.” Frontiers in Immunology 9: 2122. - PMC - PubMed

LinkOut - more resources